SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

News in brief

Icon expands UK and US labs

10-Sep-2012

Icon has added bioanalytical testing capacity at sites in the US and UK citing demand for biomarkers as the key driver for the investment.

The Ireland-based contract research organisation (CRO) added space at its facilities in Whitesboro, New York, and Manchester, UK, which will house dedicated immunoassay laboratories.

Brian O’Dwyer, senior VP of Global Bioanalytical Services at Icon said: “We have expanded our bioanalytical facilities to provide the necessary scale to support the ever-broadening range of testing services required by our sponsors.

In particular, the expansion of our dedicated biomarker testing laboratories allows us to support biomarker development programs across multiple testing platforms globally.”

Related products